Showing results (651-660 of 671) with videos related to

Sort By:
Pageof 68
Emerging Microbes & Infections|March 6, 2023
Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trialXubin Zheng, Xuwei Gui, Lan Yao, et al.
Plos Pathogens|October 31, 2015
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In VivoNatalia T Freund, Joshua A Horwitz, Lilian Nogueira, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2016
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNAJulio C C Lorenzi, Yehuda Z Cohen, Lillian B Cohn, et al.
European Heart Journal|August 21, 2003
One-year clinical outcomes of protected and unprotected left main coronary artery stentingMichael P Kelley, Bruce D Klugherz, Seyed M Hashemi, et al.
Vaccine|June 9, 2009
Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosisRonggai Sun, Yasir A W Skeiky, Angelo Izzo, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 23, 2019
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studiesPaul Guedeney, Bimmer E Claessen, Roxana Mehran, et al.
The American Journal of Cardiology|June 24, 2023
Percutaneous Coronary Intervention in Men, Women, and Minorities With a Previous Coronary Artery Bypass Graft Surgery (from the Pooled PLATINUM Diversity and PROMUS Element Plus Registries)Frans J Beerkens, Davide Cao, Wayne Batchelor, et al.
Plos Pathogens|January 26, 2016
Type I and Type II Interferon Coordinately Regulate Suppressive Dendritic Cell Fate and Function during Viral PersistenceCameron R Cunningham, Ameya Champhekar, Michael V Tullius, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 18, 2013
HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized miceJoshua A Horwitz, Ariel Halper-Stromberg, Hugo Mouquet, et al.
Hepatology (Baltimore, Md.)|March 31, 2015
Hepatitis C virus infects rhesus macaque hepatocytes and simianized miceMargaret A Scull, Chao Shi, Ype P de Jong, et al.
Pageof 68